Former Federal Official Joins Emergent Board
http://www.bizjournals.com/washington/stories/2007/06/11/daily44.html?from_rss=1
Former federal official joins Emergent board
by Neil Adler, Staff Reporter
The directors of Emergent BioSolutions Inc. appointed Sue Bailey, a physician with experience in health affairs at the Defense Department, to the company's board.
She was elected for a two-year term that will expire at Emergent's 2009 annual stockholders meeting, the Rockville-based biopharmaceutical company said in a statement Friday.
Bailey, whose career has included a faculty position at Georgetown University Medical School, was assistant secretary of defense for health affairs from 1998 to 2000, where she headed the department's $17 billion military medical system. She had served as deputy assistant secretary of defense for clinical services from 1994 to 1995.
After leaving the Defense Department, Bailey was administrator of the National Highway Traffic Safety Administration and then a news analyst for NBC from 2001 to 2006, focusing on national security, bioterrorism, environmental safety and public health.
Emergent (NYSE: EBS) has a vaccine for anthrax infection on the market. Its pipeline includes other drugs and vaccines to fight bioterror agents and infectious diseases.
Bailey received her medical degree from the Philadelphia College of Osteopathic Medicine.
Former federal official joins Emergent board
by Neil Adler, Staff Reporter
The directors of Emergent BioSolutions Inc. appointed Sue Bailey, a physician with experience in health affairs at the Defense Department, to the company's board.
She was elected for a two-year term that will expire at Emergent's 2009 annual stockholders meeting, the Rockville-based biopharmaceutical company said in a statement Friday.
Bailey, whose career has included a faculty position at Georgetown University Medical School, was assistant secretary of defense for health affairs from 1998 to 2000, where she headed the department's $17 billion military medical system. She had served as deputy assistant secretary of defense for clinical services from 1994 to 1995.
After leaving the Defense Department, Bailey was administrator of the National Highway Traffic Safety Administration and then a news analyst for NBC from 2001 to 2006, focusing on national security, bioterrorism, environmental safety and public health.
Emergent (NYSE: EBS) has a vaccine for anthrax infection on the market. Its pipeline includes other drugs and vaccines to fight bioterror agents and infectious diseases.
Bailey received her medical degree from the Philadelphia College of Osteopathic Medicine.
